Eli Lilly Prepares Billions of Doses of its new Weight Loss Pill
Reading Time: 2 minutes
Eli Lilly is on the verge of one of the largest product launches in its history. The pharmaceutical company from Indianapolis has already produced billions of doses of its new weight loss pill – even before receiving US approval. CEO Dave Ricks spoke at the Economic Club of Chicago about a "GLP-1 for everyone" that could change global access to effective treatments for obesity. The early mass production underscores how strongly Lilly anticipates global demand. Orforglipron on the verge of approval The medication named Orforglipron belongs...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
